A biotechnology company engaged in the development, production and distribution of innovative drugs created by genetic engineering
Founded in 1980, Amgen Is a leader in the biotechnology industry and one of the first companies to unlock the potential of a new generation of effective and safe drugs and fundamentally new approaches to the treatment of serious diseases.
Amgen drugs have changed everyday medical practice, helping millions of people around the world to deal with severe oncological, hematological and nephrological diseases, rheumatoid arthritis and other serious pathologies. The extensive portfolio of drugs being developed to date (more than 50 new molecules at different stages of development and research) confirms the company’s commitment to using scientific advances to improve people’s lives.
News from Amgen
The Ministry of Health of the Russian Federation has allowed simultaneous vaccination against coronavirus infection and influenza. The corresponding changes were made to the instructions for the medical use of […]
The post The Ministry of Health has allowed simultaneous vaccination against coronavirus and influenza appeared first on GxP News.
According to the instructions for the Sputnik V coronavirus vaccine published in the State Register of Medicines (GRLS), breastfeeding is no longer a contraindication for vaccination with the drug. That […]
The post The Ministry of Health approved vaccination of nursing mothers with Sputnik V appeared first on GxP News.
The Expert Council of the Industrial Development Fund approved a loan for Nanolek on Priority Projects program, according to the press center of the IDF. Nanolek, which is based in […]
The post Nanolek localizes production of active pharmaceutical substituents of HPV vaccine appeared first on GxP News.
Like 35 years ago, Amgen remains true to its mission:
"Serve patients suffering from severe diseases by developing innovative medicines to meet medical needs."
Amgen LLC, Russia, Moscow, 123112
Presnenskaya naberezhnaya 8, bld.1, fl.7
tel: +7(495)745-0478/79; fax: +7 (499) 995-1965
For information about our pipeline and therapies,
visit our official website